Home
Conditions
Non-small Cell Lung Cancer

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies

Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT04902872

Conditions: Adnexal Diseases, Appendiceal Neoplasms, Appendix Cancer, +61 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

NEXT Oncology Austin, Texas, United States

MD Anderson Cancer Center Houston, Texas, United States

NEXT Oncology San Antonio, Texas, United States

View Trial Details

Completed

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT03563716

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Arizona Oncology Associates, PC - HAL Tempe, Arizona, United States

SCRI Florida Cancer Specialists South Fort Myers, Florida, United States

Florida Cancer Specialists - NORTH - SCRI - PPDS St. Petersburg, Florida, United States

Illinois Cancer Specialists Arlington Heights, Illinois, United States

View all 40 locations

View Trial Details

Completed

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity

NCT02314481

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Univeristy College London Hospital London, United Kingdom

View Trial Details

Completed

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

NCT01625234

Conditions: Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations: City of Hope National Med Ctr Duarte, California, United States

UCSD Moores Cancer Center La Jolla, California, United States

University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States

Stanford University Stanford, California, United States

View all 14 locations

View Trial Details

Completed

Individualized Treatment Based on Epidermal Growth Factor Receptor Mutations and Level of BRCA1 Expression in Advanced Adenocarcinoma

NCT00883480

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ico-Hospital Universitarios Germans Trias I Pujol Badalona, Barcelona, Spain

Hospital Carlos Haya Málaga, Spain

View Trial Details

Completed

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

NCT02664935

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations: Aberdeen Royal Infirmary Aberdeen, United Kingdom

Belfast City Hospital, Belfast Health and Social Care Trust Belfast, United Kingdom

Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom

Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust Birmingham, United Kingdom

View all 25 locations

View Trial Details

Completed

Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer

NCT03481114

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

NCT03881488

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +32 more
Locations: Ocala Oncology Center Ocala, Florida, United States

Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer

NCT01630733

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: University Cancer Institute Boynton Beach, Florida, United States

Florida Hospital Orlando, Florida, United States

University Cancer and Blood Center, LLC Athens, Georgia, United States

Joliet Oncology-Hematology Associates Ltd. Joliet, Illinois, United States

View all 78 locations

View Trial Details

Completed

Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

NCT07526961

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Wielkopolska Center of Pulmonology and Thoracic Surgery of Eugenia and Janusz Zeyland Poznan, Poland

View Trial Details

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer trial results

Related conditions